Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol vs Ivabradine in POTS
NCT04186286Phase 2Recruiting
- Sponsor
- University of Calgary
- Start
- Feb 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivabradine in postural orthostatic tachycardia syndrome (POTS), sponsored by University of Calgary. Started Feb 2021; status: recruiting.
02
Drugs
ivabradine
03
Conditions
postural orthostatic tachycardia syndrome (POTS)
Beyond the preview
Go deeper on NCT04186286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04186286.